Recall Record

Flagstaff, AZ, United States

W L Gore & Associates, Inc. recalls

19 recalls recorded since 2018, most recently on 3 September 2026. 15 are listed as ongoing. Status and classification are as published by the FDA.

Recalls19
Ongoing (FDA)15
Terminated or completed4
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
3 September 2026
Reason
The potential for the devices to be mislabeled with the incorrect length.
Distribution
US Nationwide distribution in the states of GA, RI.
Initiated
Voluntary: Firm initiated
Recall number
Z-0158-2027

Ongoing Class II Medical devices

Recall started
22 May 2026
Reason
10 mm diameter x 7 cm with transmural drainage holes (VSWVH1006) incorrectly labeled as 10 mm diameter x 10 cm length devices without transmural drainage holes (VSWVN1010).
Distribution
U.S. Nationwide distribution in the states of GA and RI.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2914-2026, Z-2915-2026

Ongoing Class II Medical devices

Recall started
19 May 2026
Reason
Due to catheter separation
Distribution
Worldwide - U.S. Nationwide distribution including in the states and territories of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, MI, MN, MO, MT, NC, ND, NE, NJ, NM, NY, OH, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, and WI. The countries of United Arab Emirates, Australia
Initiated
Voluntary: Firm initiated
Recall number
Z-2672-2026

Ongoing Class II Medical devices

Recall started
26 August 2025
Reason
Reports of vascular graft delamination, which may lead to reduced access flow; cannulation difficulties; bleeding or bruising; and harms related to reintervention procedures, so Instructions for Use will be updated to modify existing warning to 1) further clarify techniques that may contribute to the risk of delamination, 2) Addition of delamination to device-related adverse event section.
Distribution
US: OR, AL, OH, MD, VA, CA, FL, NC, OK, MA, MO, AZ, TX, IL, GA, PA, NH, HI, MN, MS, KY, ID, LA, NJ, TN, DE, IN, MI, WI, NY, DC, SC, CT, NE, IA, WA, AR, NV, WV, AK, UT, ND, KS, CO, ME, MT, NM, SD, PR, WY, RI. OUS: PANAMA, CANADA, CHINA, TAIWAN, GERMANY, SLOVENIA, NORWAY, UNITED KINGDOM, ITALY, SPAIN
Initiated
Voluntary: Firm initiated
Recall number
Z-0036-2026

Ongoing Class II Medical devices

Recall started
3 July 2024
Reason
Devices were labeled with an expiration date of four years and ten days rather than the validated two years.
Distribution
US Nationwide distribution in the states of CA, GA, IL, NC, OH, OK, WA.
Initiated
Voluntary: Firm initiated
Recall number
Z-2513-2024

Ongoing Class II Medical devices

Recall started
1 July 2024
Reason
Due to packaging defects, sterility assurance and heparin activity may be compromised.
Distribution
Worldwide - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY and the country of Japan.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2945-2024, Z-2946-2024

Ongoing Class II Medical devices

Recall started
19 January 2024
Reason
Devices without transmural drainage holes may be mislabeled as devices with transmural drainage holes, or vice versa. Potential health impact includes extending procedure time, unplanned device removal, secondary procedure, cholangitis, cholecystitis, and/or pain. The GORE¿ VIABIL¿ Short Wire Biliary Endoprosthesis is a flexible, self-expanding endoprosthesis designed to maintain luminal patency of the common bile duct which may be obstructed. The endoprosthesis is radially compressed and secured onto the distal end of a catheter-based delivery system for deployment. The catheter provides a means for accessing and implanting the GORE¿ VIABIL¿ Short Wire Biliary Endoprosthesis at the target site in the biliary tract.
Distribution
US Nationwide distribution in the state of Georgia.
Initiated
Voluntary: Firm initiated
Recall number
Z-1179-2024

Ongoing Class II Medical devices

Recall started
14 December 2022
Reason
Septal Occluders released with incomplete quality test documentation that assesses the release of the device from the delivery system during the index procedure. A potential failure of this quality test could potentially result could result in occluder embolization, anoxic brain injury, central venous or arterial perforation or rupture.
Distribution
US Nationwide distribution in the states of NY, CA, FL, CT, TX, AR, IN, MA, MO, SD, VA.
Initiated
Voluntary: Firm initiated
Recall number
Z-1048-2023

Ongoing Class II Medical devices

Recall started
21 September 2022
Reason
Due to manufacturing records (Release Test Results) indicating "Failed".
Distribution
Worldwide distribution - U.S. Nationwide distribution including in the states of AZ, CA, CO, DC, FL, GA, IA, ID, IL, ME, MN, NC, NY, JPA, TN, TX, WA, and WI. The countries of Denmark, and Japan.
Initiated
Voluntary: Firm initiated
Recall number
Z-0136-2023

Ongoing Class II Medical devices

Recall started
7 September 2021
Reason
Incorrect labeling, specifically, expandable endoprosthesis labeled as 8 mm x 59mm x 135 cm, however may contain a 9mm x 29 mm x 135 cm device.
Distribution
International distribution to the countries of Italy & Lebanon.
Initiated
Voluntary: Firm initiated
Recall number
Z-0077-2022

Ongoing Class II Medical devices

Recall started
2 September 2021
Reason
Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.
Distribution
US: AL,AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN,MO,MS,MT,NC, ND, NE, NH, NJ, NM,NV,NY,OH,OK,OR,PA,SC,SD,TN,TX,UT,VA,VT,WA,WI, WV OUS: AUS, AUT, CAN, CHE, DEU, DNK, ESP, FRA, GBR, GRC, IRL, ITA, MEX, NLD, NOR, PRT, SAU, SWE
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0172-2022, Z-0166-2022, Z-0169-2022, Z-0165-2022, Z-0170-2022, Z-0171-2022, Z-0167-2022, Z-0164-2022, Z-0168-2022

Ongoing Class II Medical devices

Recall started
12 July 2021
Reason
Complaints received concerning Balloon Catheter leakage from the guidewire lumen and the y-hub during preparation resulting in either insufficient inflation or an inability to inflate.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY and the countries of AUS, CAN, CHE, DE
Initiated
Voluntary: Firm initiated
Recall number
Z-2340-2021

Ongoing Class II Medical devices

Recall started
12 May 2021
Reason
Vascular Grafts containing an inner diameter of 6 mm may be incorrectly labeled as 5 mm and Vascular Grafts containing an inner diameter of 5 mm are incorrectly labeled as 6 mm.
Distribution
US: NE, DC, MA, KY, IL, WA, MD, CA, AZ, GA OUS: Canada, Brazil, Europe, Saudi Arabia
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2292-2021, Z-2293-2021

Terminated Class II Medical devices

Recall started
5 April 2021
Terminated
16 January 2024
Reason
The Gore post market surveillance team received a complaint that a GORE¿ VIABIL¿ Biliary Endoprosthesis appeared shorter than the labeled length.
Distribution
Worldwide distribution - US Nationwide distribution in the states of AZ, CA, CO, CT, FL, GA, HI, IL, KS, MD, MN, NE, NY, OK, RI, TX, VA and the countries of Portugal, Italy.
Initiated
Voluntary: Firm initiated
Recall number
Z-1593-2021

Ongoing Class II Medical devices

Recall started
9 September 2020
Reason
When the delivery catheter was attempted to be removed, there was an observed connection between the stent graft and the delivery catheter that prevented the delivery catheter from being withdrawn.
Distribution
U.S. - Nationwide O.U.S. - Australia, Austria, Belgium, Croatia, Cypress, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Lebanon, Luxembourg, Monaco, Netherlands, Norway, New Zealand, Poland, Portugal, Saudi Arabia, Slovenia, South Africa, Spain
Initiated
Voluntary: Firm initiated
Recall number
Z-0291-2021

Ongoing Class II Medical devices

Recall started
9 September 2020
Reason
Due to secondary deployment fiber being attached to secondary deployment handle, completion of deployment via the deployment line access hatch was not possible
Distribution
U.S. - Nationwide O.U.S. - Australia, Austria, Belgium, Croatia, Cypress, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Lebanon, Luxembourg, Monaco, Netherlands, Norway, New Zealand, Poland, Portugal, Saudi Arabia, Slovenia, South Africa, Spain
Initiated
Voluntary: Firm initiated
Recall number
Z-0290-2021

Terminated Class II Medical devices

Recall started
6 January 2020
Terminated
9 August 2022
Reason
Firm has received reports of leading end catheter component separations.
Distribution
US: OUS: Australia; Austria; Canada; China; Taiwan; United Arab Emirates; Argentina; Brazil; Switzerland; Chile; Colombia; Costa Rica; Czechia; Spain; Greece; Croatia; Hungary; Ireland; Israel; Italy; United Kingdom; Lebanon; Mexico; New Zealand; Panama; Poland; Saudi Arabia; Slovenia; Germany; N
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0995-2020, Z-0996-2020

Terminated Class II Medical devices

Recall started
17 December 2019
Terminated
28 April 2021
Reason
The incorrect label was placed on both the primary and secondary package.
Distribution
International the country of Japan.
Initiated
Voluntary: Firm initiated
Recall number
Z-2052-2020

Terminated Class II Medical devices

Recall started
18 November 2019
Terminated
13 May 2020
Reason
The devices were mislabeled with the incorrect product size resulting in 16Fr devices being labeled as 14Fr devices.
Distribution
All distribution is foreign to the following countries: Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Japan, Norway, Spain, Sweden, Switzerland, and the UK.
Initiated
Voluntary: Firm initiated
Recall number
Z-1962-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.